PHIA Koninklijke Philips N.V.

Philips first of its kind ultrasound solution for pediatric assessment provides a gentler approach to imaging children

Philips first of its kind ultrasound solution for pediatric assessment provides a gentler approach to imaging children

May 6, 2020 

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the , the latest addition for its Philips Ultrasound System (. The new ultrasound solution provides clinicians with exceptionally detailed images and the performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps, such as X-ray imaging.

The new ultrasound solution from Philips is designed specifically for pediatric clinical use. It combines dedicated transducers, enhanced processing, and software tools that are optimized for the pediatric diagnostic workflow to help improve the experience of both young patients and staff. Children are more radiosensitive than adults, and efforts should be made to minimize risk by reducing unnecessary exposure to radiation [1]. So, a more gentle form of medical imaging is recommended when there is a clear indication for use.

“The new pediatric assessment solution on the EPIQ Elite system has elevated our ultrasound practice at Phoenix Children’s,” said Dr. Luis Goncalves, Pediatric Radiologist at Phoenix Children’s Hospital. “In particular, the solution’s new transducer offers exceptional clinical performance and versatility across many pediatric applications. For example, the intracranial detail we see in the neonatal head is truly exceptional.”

Pediatric patients come in all shapes and sizes. From the tiniest premature newborn baby to adult-sized pediatric patients, Philips offers a complete imaging solution to elevate diagnostic confidence in even the most challenging cases. The Philips ultimate ultrasound solution for pediatric assessment includes a new pediatric transducer, offering a 30% greater penetration [2] for more detailed images, and has a tailored pediatric workflow to help clinicians diagnose pediatric patients more quickly.

“Diagnostic confidence is vital for any clinician, especially when diagnosing the most sensitive patients,” said Jeff Cohen, Vice President, and General Manager General Imaging Ultrasound at Philips. “Philips ultimate ultrasound solutions provide the right level of image detail and context that clinicians need to make a precise diagnosis.”

The Philips ultimate ultrasound solution for pediatric assessment is cleared for pediatric clinical use. It extends Philips’ portfolio of dedicated solutions on the Philips Ultrasound System (EPIQ Elite) tailored to the needs of particular medical specialties. Ultrasound solutions for clinical use from Philips are available for the assessment of , , , , and now .

Availability

Philips ultimate ultrasound solution for pediatric assessment and the Ultrasound System (EPIQ Elite) update are available globally [3].

[1] /radiation-emitting-products/medical-imaging/pediatric-x-ray-imaging

[2] The new mC12-3 pediatric transducer offers 30% greater penetration in comparison to the previous generation

[3] Worldwide availability, excluding China and few other countries

For further information, please contact:

Hans Driessen

Philips Global Press Office

Tel.:

E-mail:    

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



 

Attachment

EN
06/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

Oscar Rodriguez
  • Oscar Rodriguez

PHILIPS: RDOS. 4T’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SABADELL...

Rdos. 4T’25 vs 4T’24: Ventas: 5.097 M euros (+1,1% vs -0,9% BS(e) y -1,0% consenso); EBITA Aj.: 770 M euros (+13,4% vs +0,6% BS(e) y -1,0% consenso); BDI: 397 M euros (-333 M euros en 2024 vs 275 M euros BS(e) y 276 M euros consenso); Rdos. 2025 vs 2024: Ventas: 17.834 M euros (-1,0% vs -1,6% BS(e) y -1,6% consenso); EBITA Aj.: 2.195 M euros (+5,7% vs +1,5% BS(e) y +1,0% consenso); BDI: 897 M euros (-698 M euros en 2024 vs 775 M euros BS(e) y 776 M euros consenso).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch